By using the members area you have already agreed to share your personal information with the BGMA/BBA so that you can access the members materials. We will store your details only as long as you are a member. Your personal information will not be shared any affiliated companies or third parties. For more information about our Privacy Policy, click here.
Making medicines more affordable to the NHS and therefore increasing patient access to important, and potentially life-saving, drugs is a key role of the UK generic and biosimilar medicines industry.
Read more
Generic medicines in the UK must comply with exactly the same standards of quality, safety and efficacy as all medicinal products.
Read more
The UK generics industry is the engine room behind a virtuous circle of innovation and cost containment.
Read more
The generic industry in the UK is amongst the most efficient in the world with prices currently amongst the lowest in Europe.
Read more
The UK generics industry is a key part of an efficient supply chain which ensures patients access the medicines they need in a timely and affordable manner.
Read more